POSTSURGICAL ADJUVANT THERAPY IN STAGE-I, STAGE-II, AND STAGE-IIIA NON-SMALL-CELL LUNG-CANCER

被引：0
|
作者：
LAD, TE
机构：
[1] UNIV ILLINOIS HOSP, DEPT MED, ONCOL SECT, CHICAGO, IL 60612 USA
[2] VET ADM W SIDE MED CTR, ONCOL SECT, CHICAGO, IL 60680 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1990年 / 4卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1111 / 1119
页数：9
相关论文
共 50 条
  • [31] NUCLEOLAR ORGANIZER REGIONS AS A PROGNOSTIC INDICATOR FOR STAGE-I NON-SMALL-CELL LUNG-CANCER
    KANEKO, S
    ISHIDA, T
    SUGIO, K
    YOKOYAMA, H
    SUGIMACHI, K
    CANCER RESEARCH, 1991, 51 (15) : 4008 - 4011
  • [32] Resected non-small-cell lung cancer stage I/II: Indication for adjuvant/neoadjuvant therapy?
    Hoffmann, H
    LUNG CANCER, 2004, 45 : S91 - S97
  • [33] Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer
    Scagliotti, GV
    Fossati, R
    Torri, V
    Crinó, L
    Giaccone, G
    Silvano, G
    Martelli, M
    Clerici, M
    Cognetti, F
    Tonato, M
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19): : 1453 - 1461
  • [34] ADVERSE EFFECT OF INTRAPLEURAL CORYNEBACTERIUM-PARVUM AS ADJUVANT THERAPY IN RESECTED STAGE-I AND STAGE-II NON-SMALL CELL-CARCINOMA OF THE LUNG
    KAUFMANN, M
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1985, 89 (06): : 842 - 847
  • [35] Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer - The Movsas article reviewed
    Wagner, H
    ONCOLOGY-NEW YORK, 2002, 16 (01): : 105 - 106
  • [36] Management of non-small-cell lung cancer (stage IIIa)
    Gridelli, C
    Rossi, A
    Guerriero, C
    Ferrara, C
    Del Gaizo, F
    Colantuoni, G
    Salerno, V
    Nicolella, D
    TUMORI JOURNAL, 2003, : S103 - S105
  • [37] Adjuvant Therapy for Stage I and II Non-Small Cell Lung Cancer
    Naylor, Evan C.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 585 - +
  • [38] Adjuvant therapy for stage I and II non-small cell lung cancer
    Dorr, VJ
    Perry, MC
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (02) : 267 - +
  • [39] MULTIMODALITY THERAPY OF PATIENTS WITH STAGE-IIIA, N2 NON-SMALL-CELL LUNG-CANCER - IMPACT OF PREOPERATIVE CHEMOTHERAPY ON RESECTABILITY AND DOWNSTAGING
    KIRN, DH
    LYNCH, TJ
    MENTZER, SJ
    LEE, TH
    STRAUSS, GM
    ELIAS, AD
    SKARIN, AT
    SUGARBAKER, DJ
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (04): : 696 - 702
  • [40] TREATMENT OF STAGE-I AND STAGE-II ORAL TONGUE CANCER
    LYDIATT, DD
    ROBBINS, KT
    BYERS, RM
    WOLF, PF
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1993, 15 (04): : 308 - 312
12345